Covid-19

THE FIRST COVID-19

SEVERITY SCORE

FACILITATING PATIENT TRIAGE

Discover

The abioSCOPE®

The innovative, Swiss-made, in vitro diagnostic (IVD) point-of-care system that ...

10-9
…uses proprietary nanofluidic technology and…
1
…one drop of capillary blood to…
14
…analyse up to 14 parameters simultaneously in…
5
…about 5 minutes.
Abioscope Platform

The abioscope® platform

Provides healthcare professionals ultra-rapid panel solutions cost-effectively at the point of care

Discover

Disruptive nanofluidic technology

  • Rapid turnaround time
  • Laboratory quality results
  • Easily handled by lay user

Multiplexing immunoassay panel

  • Up to 14 parameters
  • Tailored panel options
  • One drop of capillary blood

Our focus is to provide timely answer to patients care.
Discover our clinical applications scope at the point of care.

Cardiovascular diseases
Sepsis & infectious diseases
Critical care
IMMUNOLOGY & ENDOCRINOLOGY

Disease
areas

Metabolism
Therapeutic drug monitoring
HAEMATOLOGY
Traumatic brain injuries
The first of our commitments:

Fighting sepsis

Five minutes to save lives

As a member of the Global Sepsis Alliance (GSA), Abionic is an active ambassador for fighting sepsis.

Tom’s story
About Us

Abionic, based in the Biopole of Lausanne, is a spin-off from EPFL with multiple patent protections for its disruptive nanofluidic technology.

The abioSCOPE® is the achievement of ten years of R&D at the heart of the Swiss Health Valley.

Discover